Sabri Kourosh, Woodward Mary Angela, Easterbrook Bethany, Shivananda Sandesh
Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
McMaster Paediatric Eye Research Group, Department of Surgery, McMaster University, Hamilton, ON, Canada.
J Perinatol. 2018 Apr;38(4):381-385. doi: 10.1038/s41372-017-0030-6. Epub 2018 Jan 2.
To examine current level three Neonatal Intensive Care Unit (NICU) practices related to ROP screening and treatment.
A cross-sectional survey was sent to 29 level three NICU's across Canada to survey current screening inclusion criteria, treatment options, supportive care and post-screening events for ROP.
22/29 (76%) level three NICU's responded. Ten different ROP screening inclusion criteria were found to be in use with significant variation in gestational age and birth weight criteria. Many other national variations also exist regarding the supportive and procedural protocols surrounding ROP screening as well as mode of treatment for ROP.
Despite national guidelines, significant variation in ROP screening inclusion criteria practices exist among neonatal units in Canada. Therefore, there is an urgent need for better evidence-based screening guidelines as well as a need to standardize supportive measures surrounding ROP screening and treatment.
研究当前三级新生儿重症监护病房(NICU)与视网膜病变(ROP)筛查及治疗相关的实践情况。
向加拿大29家三级NICU发送了横断面调查问卷,以调查当前ROP的筛查纳入标准、治疗选择、支持性护理及筛查后情况。
29家三级NICU中有22家(76%)做出回应。发现有10种不同的ROP筛查纳入标准在使用,胎龄和出生体重标准存在显著差异。在围绕ROP筛查的支持性和程序性方案以及ROP的治疗方式方面,也存在许多其他国家差异。
尽管有国家指南,但加拿大各新生儿病房在ROP筛查纳入标准实践方面存在显著差异。因此,迫切需要更好的循证筛查指南,以及规范围绕ROP筛查和治疗的支持性措施。